The prevalence of migraine in restless legs syndrome

Headache

Volumn 54, Issue 5, 2014, Pages 872-877

  Gozubatik Celik, Gokcen ^a   Benbir, Gulcin ^a   Tan, Funda ^a   Karadeniz, Derya ^a   Goksan, Baki ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

migraine; prevalence; restless legs syndrome

Indexed keywords

DOPAMINE 3 RECEPTOR STIMULATING AGENT; GABAPENTIN; IRON; LEVODOPA; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN UPTAKE INHIBITOR; PREGABALIN; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; FOLLOW UP; GENDER; HUMAN; INTERNATIONAL RESTLESS LEGS SYNDROME STUDY GROUP SEVERITY SCALE; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; PREVALENCE; PRIORITY JOURNAL; RATING SCALE; RESTLESS LEGS SYNDROME; SECONDARY HEADACHE; TENSION HEADACHE; COMPLICATION; MIGRAINE DISORDERS;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PREVALENCE; RESTLESS LEGS SYNDROME;

EID: 84899947220     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/head.12288     Document Type: Article

References (24)

1. Walters AS, for the International Restless Legs Syndrome Study Group. Toward a better definition of restless legs syndrome. Mov Disord. 1995; 10: 634-642.
2. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J,. Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group. Restless legs syndrome: Diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003; 4: 101-119.
3. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C,. Epidemiology of restless legs symptoms in adults. Arch Intern Med. 2000; 160: 2137-2141.
4. Zucconi M, Ferini-Strambi L,. Epidemiology and clinical findings of restless legs syndrome. Sleep Med. 2004; 5: 293-299.
5. Turkdogan D, Bekiroglu N, Zaimoglu S,. A prevalence study of restless legs syndrome in Turkish children and adolescents. Sleep Med. 2011; 12: 315-321.
6. Sevim S, Dogu O, Camdeviren H, et al. Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. Neurology. 2003; 61: 1562-1569.
7. Ardic S, Demir AU, Firat H, et al. Prevalence of sleep disorders in the Turkish Adult Population Epidemiology of Sleep (TAPES) Study: A Questionnaire based national Survey. Sleep Breath. 2013; in press.
8. Ondo WG, He Y, Rajasekaran S, Le WD,. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: A possible model for restless legs syndrome. Mov Disord. 2000; 15: 154-158.
9. Robbins MS, Lipton RB,. The epidemiology if primary headache disorders. Semin Neurol. 2010; 30: 107-119.
10. D'Onofrio F, Bussone G, Cologno D, et al. Restless legs syndrome and primary headaches: A clinical study. Neurol Sci. 2008; 29: 169-172.
11. Rhode AM, Hosing VG, Happe S,. Comorbidity of migraine and restless legs syndrome: A case control study. Cephalalgia. 2007; 27: 1255-1260.
12. The International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003; 4: 121-132.
13. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia. 2004; 24: 60-63.
14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association; 2000. text rev.
15. Smitherman TA, Burch R, Sheikh H, Loder E,. The prevalence, impact, and treatment of migraine and severe headaches in the United States: A review of statistics from national surveillance studies. Headache. 2013; 53: 427-436.
16. Benbir G, Karadeniz D, Goksan B,. The characteristics and subtypes of headache in relation to age and gender in a rural community in Eastern Turkey. Agri. 2012; 24: 145-152.
17. Zarifoglu M, Siva A, Hayran O, Thes G,. An epidemiological study of headache in Turkey: A nationwide survey. Neurology. 1998; 50: A225.
18. Lavados PM, Tenhamm E,. Epidemiology of migraine headache in Santiago, Chile: A prevalence study. Cephalalgia. 1997; 17: 770-777.
19. Ertas M, Baykan B, Orhan EK, et al. One-year prevalence and the impact of migraine and tension-type headache in Turkey: A nationwide home-based study in adults. J Headache Pain. 2012; 13: 147-157.
20. Gupta R, Lahan V, Goel D,. Primary headaches in restless legs syndrome patients. Ann Indian Acad Neurol. 2012; 15: 104-108.
21. Young WB, Piovesan E, Biglan KM,. Restless legs syndrome and drug-induced akathesia in headache patients. CNS Spectr. 2003; 6: 450-456.
22. Chen PK, Fuh JL, Chen SP, Wang SJ,. Association between restless legs syndrome and migraine. J Neurol Neurosurg Psychiatry. 2010; 81: 524-528.
23. Silberstein SD,. Association between restless legs syndrome and migraine. J Neurol Neurosurg Psychiatry. 2010; 81: 473-475.
24. Charbit A, Akerman S, Holland PR, Goadsby PJ,. Neurons of the dopaminergic/calcitonin gene-related peptide A11 cell group modulate neuronal firing in the trigeminocervical complex: An electrophysiological and immunohistochemical study. J Neurosci. 2009; 29: 12532-12541.